South & Central America Microcarriers Market Forecast to 2030

According to the Research Team research, the South & Central America microcarriers market was valued at US$ 68.77 million in 2022 and is expected to reach US$ 129.96 million by 2030, registering a CAGR of 8.3% from 2022 to 2030. Strategic initiatives and innovative products by microcarrier manufacturers and infectious diseases and increasing popularity of outsourcing cell and gene therapy manufacturing are among the critical factors attributed to the South & Central America microcarriers market expansion.

Companies operating in the microcarriers market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the microcarriers market are mentioned, In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US. In June 2023, Teijin Frontier introduced new nonwoven microcarriers that enable speedy, large-scale, high-quality cell culture. The new nonwoven microcarriers combine Teijin Frontier’s proprietary fiber process and nonwoven design technology, and fiber-related biomedical expertise by the Faculty of Engineering, University of Fukui, Japan. In October 2023, Semarion, unveiled the Early Adopter Programme for its SemaCyte Microcarrier Platform. SemaCytes developed by Semarion are cell carrier materials created using microchip fabrication technologies, nanomagnetism, and smart materials. These assaying microcarriers are flat and function as ultraminiaturized, magnetically steerable wells that carry small colonies of adherent cells into suspension to improve cell-based experiments. In November 2020, researchers from the Singapore-MIT Alliance for Science and Technology (SMART) developed a novel microcarrier for large-scale cell production and cell expansion. Employing this microcarrier would allow businesses to have higher yields in a more cost-effective way than traditional methods while lowering the number of steps involved in the cell retrieval process. This newly developed dissolvable Gelatin microcarrier from SMART can be used in cell expansion for treating various ailments, including bone and cartilage defects, and graft vs. host disease, i.e., the rejection of foreign bone marrow and cells. Therefore, introducing products such as PVA hydrogel microcarriers, nonwoven microcarriers, and SemaCyte microcarrier platform, and the initiation of new businesses through collaborations and partnerships to remain competitive in the market would create significant growth opportunities in the microcarriers market.

On the contrary, high cost of biologics and cell-based therapies hampers the South & Central America microcarriers market.

Based on product, the South & Central America microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held 69.5% share of South & Central America microcarriers market in 2022, amassing US$ 47.80 million. It is projected to garner US$ 91.88 million by 2030 to expand at 8.5% CAGR during 2022-2030.

In terms of equipment, the South & Central America microcarriers market is categorized into bioreactors, culture vessels, and others. The bioreactors segment held 63.9% share of South & Central America microcarriers market in 2022, amassing US$ 43.93 million. It is projected to garner US$ 84.66 million by 2030 to expand at 8.5% CAGR during 2022-2030.

Based on application, the South & Central America microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production beads segment held 52.1% share of South & Central America microcarriers market in 2022, amassing US$ 35.82 million. It is projected to garner US$ 70.31 million by 2030 to expand at 8.8% CAGR during 2022-2030. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.

Based on end user, the South & Central America microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held 55.6% share of South & Central America microcarriers market in 2022, amassing US$ 38.23 million. It is projected to garner US$ 74.01 million by 2030 to expand at 8.6% CAGR during 2022-2030.

By country, the South & Central America microcarriers market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 56.5% share of South & Central America microcarriers market in 2022. It was assessed at US$ 38.82 million in 2022 and is likely to hit US$ 75.03 million by 2030, exhibiting a CAGR of 8.6% during 2022-2030.

Key players operating in the South & Central America microcarriers market are Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc, among others.

In May 2022, Saint-Gobain Life Sciences released beadMATRIX for mesenchymal stromal cells (MSCs). beadMATRIX are ready-to-use, pre-coated microcarriers free of animal components that are used to cultivate superior MSCs in vitro. Shaker bags, stirred tanks, vertical wheel bioreactors, and shaker flasks are the perfect environments for beadMATRIX

Table 1. Microcarriers Market Segmentation
Table 2. Brazil Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 3. Brazil Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 4. Brazil Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 5. Brazil Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 6. Brazil: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 7. Argentina Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 8. Argentina Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 9. Argentina Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 10. Argentina Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 11. Argentina: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 12. Rest Of South & Central America Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 13. Rest Of South & Central America Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 14. Rest Of South & Central America Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 15. Rest Of South & Central America Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 16. Rest Of South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 17. Recent Organic Growth Strategies in Microcarriers Market
Table 18. Recent Inorganic Growth Strategies in the Microcarriers Market
Table 19. Glossary of Terms

Figure 1. Microcarriers Market Segmentation, By Country
Figure 2. Key Insights
Figure 3. Microcarriers Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market
Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
Figure 7. Microcarrier Beads: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Media and Reagents: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 10. Bioreactors: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Culture Vessels: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Biopharmaceutical Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Therapeutic Protein Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Vaccine Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cell and Gene Therapy: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. South & Central America Microcarriers Market Share by End User – 2022 & 2030 (%)
Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 24. Microcarriers Market, 2022 (US$Mn)
Figure 25. South & Central America: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 26. Brazil: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)